A PROSPECTIVE OBSERVATIONAL STUDY ON ANTIBIOTIC USAGE TRENDS, RISK FACTORS AND 28 DAYS MORTALITY RATE ASSOCIATED WITH VENTILATOR-ASSOCIATED PNEUMONIA AMONG MEDICAL ICU PATIENTS: INSIGHTS FROM A TERTIARY CARE HOSPITAL
dc.contributor.author | PARTHASARATHY, R | en_US |
dc.contributor.author | SUNNY, AA. | en_US |
dc.date.accessioned | 2025-05-12T07:20:51Z | |
dc.date.available | 2025-05-12T07:20:51Z | |
dc.date.issued | 2024-08 | |
dc.description.abstract | Objective: This study was conducted to investigate the antibiotic usage, risk factors and mortality associated with the development of VAP (Ventilator Associated Pneumonia). Methods: An open–labelled, prospective, observational (case-control) study was carried out for 6 mo in the Department of Critical Care Medicine. Initial screening was done based on inclusion and exclusion criteria and 58 patients were found eligible. The statistical analysis was done using the Chi-Square test and t-test. Results: The incidence of VAP in our study was 6.07%. Prolonged hospitalisation (p=0.00) and ICU stay (p=0.00) showed a statistically significant association with the development of VAP and they possessed a high risk of carbapenem-resistant organisms in the age group more than 60 years. Colistin therapy alone and/or combined with tigecycline therapy showed 100% survival. SOFA (Sequential Organ Failure Assessment) scoring done before and after VAP diagnosis showed a significant difference (p<0.005). Our study revealed that mortality was high in patients with SOFA score range of 7-9. Conclusion: The lower incidence of VAP points out the good infection control practices in the ICU (Intensive Care Unit). Late-onset VAP was more prevalent with Acinetobacter baumannii. Prolonged hospitalization and ICU stay were the significant risk factors. Colistin therapy alone and/or in combination with tigecycline was the most effective treatment. | en_US |
dc.identifier.affiliations | Department of Pharmacy Practice, PSG College of Pharmacy, Coimbatore-641004, Tamil Nadu, India | en_US |
dc.identifier.affiliations | Department of Neurology, KMCH Hospitals, Coimbatore-641004, Tamil Nadu, India | en_US |
dc.identifier.citation | PARTHASARATHY R, SUNNY AA.. A PROSPECTIVE OBSERVATIONAL STUDY ON ANTIBIOTIC USAGE TRENDS, RISK FACTORS AND 28 DAYS MORTALITY RATE ASSOCIATED WITH VENTILATOR-ASSOCIATED PNEUMONIA AMONG MEDICAL ICU PATIENTS: INSIGHTS FROM A TERTIARY CARE HOSPITAL . International Journal of Pharmacy and Pharmaceutical Sciences . 2024 Aug; 16(8): 21-26 | en_US |
dc.identifier.issn | 0975-1491 | |
dc.identifier.issn | 2656-0097 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/246460 | |
dc.language | en | en_US |
dc.publisher | Innovare Academic Sciences Pvt. Ltd. | en_US |
dc.relation.issuenumber | 8 | en_US |
dc.relation.volume | 16 | en_US |
dc.source.uri | https://doi.org/10.22159/ijpps.2024v16i8.51599 | en_US |
dc.subject | Ventilator-associated Pneumonia | en_US |
dc.subject | Mortality rate | en_US |
dc.subject | Antibiotics | en_US |
dc.subject | Prescribing pattern | en_US |
dc.title | A PROSPECTIVE OBSERVATIONAL STUDY ON ANTIBIOTIC USAGE TRENDS, RISK FACTORS AND 28 DAYS MORTALITY RATE ASSOCIATED WITH VENTILATOR-ASSOCIATED PNEUMONIA AMONG MEDICAL ICU PATIENTS: INSIGHTS FROM A TERTIARY CARE HOSPITAL | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ijpps2024v16n8p21.pdf
- Size:
- 1.22 MB
- Format:
- Adobe Portable Document Format